Submitted by Anonymous (not verified) on 14 January 2026 - 15:28
Human medicines European public assessment report (EPAR): Roctavian, valoctocogene roxaparvovec, Date of authorisation: 24/08/2022, Revision: 10, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Roctavian, valoctocogene roxaparvovec, Date of authorisation: 24/08/2022, Revision: 10, Status: Authorised